We are live on ! Find out more
VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

4 hedge funds and large institutions have $4.25M invested in Pacer BioThreat Strategy ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

24,900% more capital invested

Capital invested by funds: $17K → $4.25M (+$4.23M)

300% more funds holding

Funds holding: 1 → 4 (+3)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IAIM
International Assets Investment Management
Florida
+$2.93M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$823K
3
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$289K
4
Osaic Holdings
Osaic Holdings
Arizona
+$34.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
IAIM
1
International Assets Investment Management
Florida
$3.05M +$2.93M +108,640 New
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$869K +$823K +30,544 +4,505%
Cambridge Investment Research Advisors
3
Cambridge Investment Research Advisors
Iowa
$299K +$289K +10,739 New
Osaic Holdings
4
Osaic Holdings
Arizona
$36K +$34.8K +1,293 New

VIRS Hedge Fund Activity: Q3 2020 in Review

4 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q3 2020, worth a combined $4.25M — up 24,900% from $17K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VIRS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was International Assets Investment Management, opening a new position worth an estimated $2.93M.

  • 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q3 2020, up from 1 in Q2 2020.
  • Funds reported $4.25M of Pacer BioThreat Strategy ETF stock for Q3 2020, up 24,900% quarter-over-quarter.
  • 3 funds opened new Pacer BioThreat Strategy ETF positions in Q3 2020 and 0 closed out, a net change of +3 holders.
  • The largest Pacer BioThreat Strategy ETF buyer in Q3 2020 was International Assets Investment Management, an estimated $2.93M added.

Based on aggregated 13F filings for Q3 2020.